Biotech

All Articles

AC Immune observes 'site' potential in Alzheimer's drug records

.After much more than 20 years of service neurodegenerative conditions, Swiss biotech AC Invulnerabl...

GSK drops ph. 2 HPV vaccine over shortage of best-in-class prospective

.GSK has actually ditched a stage 2 individual papillomavirus (HPV) injection from its pipe after ma...

OS Therapies refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.OS Therapies are going to provide on the NYSE American stock swap today using a $6.4 million IPO th...

ALX's waning CD47 reaction price sends out inventory spiraling down

.ALX Oncology's period 2 gastric cancer reaction cost has weakened. After seeing its own CD47 blocke...

Ionis centers eye condition coming from targets of Roche-partnered possibility after records disappoint

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has disappointed requirements, ...

Biogen's CEO pointed out no unsafe deals in 2023. He's ready to be strong

.While Biogen's pharma peers are searching for late-stage possessions with little threat, chief exec...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has been actually a biotech looking for a pipeline after it junked its own lead as...

Biogen leaves Denali Alzheimer's collab

.Biogen has handed back civil liberties to an early Alzheimer's disease course to Denali Therapies, ...

Takeda taps brand-new mind people oncology service-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and al...

Vertex, beaten by AATD once again, loses 2 properties on dispose of pile

.Tip's effort to alleviate an uncommon genetic illness has attacked yet another drawback. The biotec...